chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Malaise, Muscular weakness, Myalgia, Pain in extremity
Clinical narrative: Muscle pain in the left upper arm after the 2nd dose even though my shot was in the right arm. Adverse effects that started this past summer were nose bleeds which I have never had before, tingling in my arms and numbness in my hands. I have brain fog , weakness and reoccurring pain in my left arm.  Some days I do not feel well and have no energy.  I also got sick with the flu  2 months after the vaccination.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Muscle pain in the left upper arm after the 2nd dose even though my shot was in the right arm. Adverse effects that started this past summer were nose bleeds which I have never had before, tingling in my arms and numbness in my hands. I have brain fog , weakness and reoccurring pain in my left arm.  Some days I do not feel well and have no energy.  I also got sick with the flu  2 months after the vaccination.
Age: 74.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Angiogram cerebral, Arteriogram carotid, Computerised tomogram, Magnetic resonance imaging, Nausea
Clinical narrative: Vertigo, Vomiting, Nausea
Age: 74.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vertigo, Vomiting
Clinical narrative: Vertigo, Vomiting, Nausea
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Diarrhoea, Fatigue, Pain, Pyrexia
Clinical narrative: Severe vomiting starting about eight hours after vaccination, occurring about every half hour for about five hours.   Also diarrhea and body aches.  Rigors (uncontrollable trembling chills) and fever of 100.8.  Fever was gone by noon the next day but body aches and fatigue remained. Since severe vomiting is not reported as a side effect of RSV vaccine I decided to report to make this adverse event of this vaccine known.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Tremor, Vomiting
Clinical narrative: Severe vomiting starting about eight hours after vaccination, occurring about every half hour for about five hours.   Also diarrhea and body aches.  Rigors (uncontrollable trembling chills) and fever of 100.8.  Fever was gone by noon the next day but body aches and fatigue remained. Since severe vomiting is not reported as a side effect of RSV vaccine I decided to report to make this adverse event of this vaccine known.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Rash, Rash pruritic
Clinical narrative: 11/07/2023- had a strong metallic taste in mouth 11/08/2023- broke out with an itchy rash across neck and upper chest area
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error
Clinical narrative: Patient received Moderna Spikevax 2023-2024 Formula on 10/30/23.  Our team was given some training before administering the vaccine, but we did not know that the vaccine needed a thaw time and Medical Assistant was applying heat to the frozen vaccine with her hands for up to 15-20 min until it turned into liquid. Patient has been called and stated no symptoms signs or any effects after receiving the vaccine.
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: Blindness, Hypotension, Incoherent, Mydriasis, Presyncope
Clinical narrative: After giving pt influenza imz, I was giving big brother imz.  As I was giving big brother IMZ, mom was holding pt.  She put pt on the ground and his pupils were enlarged and he told his mom he can't see.  I had him sit in chair and took his blood pressure.  His blood pressure was low 85/44.  When he sat in the chair, he wasn't completely coherent for a few seconds.  He would answer a question, but then would seem to become incoherent again.  After about 10-20 seconds, he was coherent and stayed that way for the remainder of the time.  I told technician to call EMS to make sure everything was going to be ok with pt.  Pt's bp was still low but came up gradually.  After about 5 minutes, pt's bp came back up to 113/68.  Right after that the paramedics came and checked the patient out and said everything was fine.  Pt's vitals came back to normal while paramedics were here.  Pt did not have an allergic reaction to flu vaccine, but seemed to have a vasovagal reaction to having imz.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site reaction, Peripheral swelling, Tenderness
Clinical narrative: Patient came into the pharmacy today with an injection site reaction. Patient's arm was swollen, red, tender to the touch, and sore which started the day after vaccination was given.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infecection
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error
Clinical narrative: Patient received Moderna Spikevax 2023-2024 Formula on 10/30/23.  Our team was given some training before administering the vaccine, but we did not know that the vaccine needed a thaw time and Medical Assistant was applying heat to the frozen vaccine with her hands for up to 15-20 min until it turned into liquid. Patient has been called and stated no symptoms signs or any effects after receiving the vaccine.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Patient presented to clinic for Moderna Covid19 vaccine administration on 11/6 ~0800.  Spikevax 0.5ml was given in right deltoid.  Lot #8058876.  Patient also had a breakfast drink contaminated with "little dry pack thing" mixed in without realizing this was the case until that evening.  After the end of the 15 minute waiting period, patient complained of bilateral pruritis on both arms.  On exam, provider states there was a rash on the arms.  Patient self medicated with 25mg diphenhydramine with resolution.  Rash reoccurred that evening but was managed with diphenhydramine without recurrence.   Unclear if patient had reaction to vaccine or to the contents in the breakfast drink.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood creatinine, Blood culture, Blood glucose increased, Blood lactic acid normal
Clinical narrative: Admission Date: 8/28/2023 Discharge Date: Aug 29, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 83 y.o. male with a history of CAD, HTN, HLD, diet controlled DM II, tobacco use, OSA, and CKD III who presents to the ED at the insistence of family members due to worsening generalized weakness.  The patient insists he has been feeling overall ?fine? he has been weaker and not eating very much.  He had a fall on Friday 8/25, characterized as slipping out of bed, landing on his knees without loss of consciousness or acute injury.     In the ER, patient was febrile to 102 F, but not tachycardic or hypoxic. BP borderline low but asymptomatic. Labs showed mild hyponatremia, na 133, Cr 1.35 (slightly above baseline), gluc 250, no leukocytosis, normal lactic. Initially concern for sepsis so blood cultures obtained and pt received 2L fluid bolus and zosyn IV empirically. Fever improved with tylenol. COVID test returned positive. CXR showed no acute findings but small asymmetric nodular opacity LUL possibly infectious vs malignancy. Due to generalized weakness in COVID-19, he was placed in observation with internal medicine for further evaluation and treatment.   The patient remained on room air during his hospitalization.  It was discussed with him the CT findings and he chose to follow up with primary care doctor for repeat CT scan of the thorax to monitor the lung mass.  PT/OT did evaluate the patient and recommended home assist with home health care and PT/OT.  Patient was doing well overall therefore he was discharged in a stable condition.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, Chest X-ray abnormal, Computerised tomogram, Decreased appetite
Clinical narrative: Admission Date: 8/28/2023 Discharge Date: Aug 29, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 83 y.o. male with a history of CAD, HTN, HLD, diet controlled DM II, tobacco use, OSA, and CKD III who presents to the ED at the insistence of family members due to worsening generalized weakness.  The patient insists he has been feeling overall ?fine? he has been weaker and not eating very much.  He had a fall on Friday 8/25, characterized as slipping out of bed, landing on his knees without loss of consciousness or acute injury.     In the ER, patient was febrile to 102 F, but not tachycardic or hypoxic. BP borderline low but asymptomatic. Labs showed mild hyponatremia, na 133, Cr 1.35 (slightly above baseline), gluc 250, no leukocytosis, normal lactic. Initially concern for sepsis so blood cultures obtained and pt received 2L fluid bolus and zosyn IV empirically. Fever improved with tylenol. COVID test returned positive. CXR showed no acute findings but small asymmetric nodular opacity LUL possibly infectious vs malignancy. Due to generalized weakness in COVID-19, he was placed in observation with internal medicine for further evaluation and treatment.   The patient remained on room air during his hospitalization.  It was discussed with him the CT findings and he chose to follow up with primary care doctor for repeat CT scan of the thorax to monitor the lung mass.  PT/OT did evaluate the patient and recommended home assist with home health care and PT/OT.  Patient was doing well overall therefore he was discharged in a stable condition.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hyponatraemia, Hypotension, Joint injury, Lung opacity
Clinical narrative: Admission Date: 8/28/2023 Discharge Date: Aug 29, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 83 y.o. male with a history of CAD, HTN, HLD, diet controlled DM II, tobacco use, OSA, and CKD III who presents to the ED at the insistence of family members due to worsening generalized weakness.  The patient insists he has been feeling overall ?fine? he has been weaker and not eating very much.  He had a fall on Friday 8/25, characterized as slipping out of bed, landing on his knees without loss of consciousness or acute injury.     In the ER, patient was febrile to 102 F, but not tachycardic or hypoxic. BP borderline low but asymptomatic. Labs showed mild hyponatremia, na 133, Cr 1.35 (slightly above baseline), gluc 250, no leukocytosis, normal lactic. Initially concern for sepsis so blood cultures obtained and pt received 2L fluid bolus and zosyn IV empirically. Fever improved with tylenol. COVID test returned positive. CXR showed no acute findings but small asymmetric nodular opacity LUL possibly infectious vs malignancy. Due to generalized weakness in COVID-19, he was placed in observation with internal medicine for further evaluation and treatment.   The patient remained on room air during his hospitalization.  It was discussed with him the CT findings and he chose to follow up with primary care doctor for repeat CT scan of the thorax to monitor the lung mass.  PT/OT did evaluate the patient and recommended home assist with home health care and PT/OT.  Patient was doing well overall therefore he was discharged in a stable condition.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pulmonary mass, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 8/28/2023 Discharge Date: Aug 29, 2023 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 83 y.o. male with a history of CAD, HTN, HLD, diet controlled DM II, tobacco use, OSA, and CKD III who presents to the ED at the insistence of family members due to worsening generalized weakness.  The patient insists he has been feeling overall ?fine? he has been weaker and not eating very much.  He had a fall on Friday 8/25, characterized as slipping out of bed, landing on his knees without loss of consciousness or acute injury.     In the ER, patient was febrile to 102 F, but not tachycardic or hypoxic. BP borderline low but asymptomatic. Labs showed mild hyponatremia, na 133, Cr 1.35 (slightly above baseline), gluc 250, no leukocytosis, normal lactic. Initially concern for sepsis so blood cultures obtained and pt received 2L fluid bolus and zosyn IV empirically. Fever improved with tylenol. COVID test returned positive. CXR showed no acute findings but small asymmetric nodular opacity LUL possibly infectious vs malignancy. Due to generalized weakness in COVID-19, he was placed in observation with internal medicine for further evaluation and treatment.   The patient remained on room air during his hospitalization.  It was discussed with him the CT findings and he chose to follow up with primary care doctor for repeat CT scan of the thorax to monitor the lung mass.  PT/OT did evaluate the patient and recommended home assist with home health care and PT/OT.  Patient was doing well overall therefore he was discharged in a stable condition.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Computerised tomogram head, Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Magnetic resonance imaging
Clinical narrative: PT was hospitalized with a progressive Neurologic deficit starting on 10/10/23 starting with leg weakness and which progressed to patient becoming unresponsive.  She was hospitalized for over 2 weeks, it slowly improved. The working diagnosis in hindsight is Guillain-Barre Syndrome.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Nervous system disorder, Unresponsive to stimuli
Clinical narrative: PT was hospitalized with a progressive Neurologic deficit starting on 10/10/23 starting with leg weakness and which progressed to patient becoming unresponsive.  She was hospitalized for over 2 weeks, it slowly improved. The working diagnosis in hindsight is Guillain-Barre Syndrome.
Age: 75.0
Sex: M
Vaccine: RSV
Symptoms: Fatigue, Malaise, Pain
Clinical narrative: Pt reported aches and pain and fatigue. General not feeling well. Reported on 11/6/23 and patient said from time of vaccine until he informed us.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Multiple sclerosis relapse, Pyrexia, Unresponsive to stimuli
Clinical narrative: Fever of 102.4 and unresponsive, Sent resident to ER on 11/3/23. resident  readmitted to facility on 11/6/23
Age: 16.0
Sex: M
Vaccine: FLU4, MENB, MNQ
Symptoms: Euphoric mood, Fall, Head injury, Hyperhidrosis, Nausea
Clinical narrative: Patient was sitting on the exam table and Medical assistant administered Men B (Bexsero) right arm and then administered MCV-4 (Menveo) Left arm, was administering the Flulaval on the left arm and patient started to go forward and feel and hit head on tile floor. Mom lay patient on the floor flat while Medical Assistant went to grab a provider.  When Medical assistant and provider enter the patient exam room patient was already on the exam table sitting up, provider told patient to lay down, asked patient if he was nausea, sweaty or felt hot and patient said yes to all 3 questions. Provider bent patient legs and had patient wait for about 10mins and provider was in the room the whole time. Provider wait till patient felt better and was not pale no more and escorted him to car.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 76.0
Sex: M
Vaccine: RSV
Symptoms: Herpes zoster
Clinical narrative: The report I am making today is about shingles which were first observed on 11/6/2023. I didn't have any other symptoms after the vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Cardiac failure congestive
Clinical narrative: Patient recently tested positive for COVID-19 approximately 9 days prior to presentation.  He currently presented to the hospital with worsening shortness of breath that started approximately 1 week prior to presentation.In the emergency room she was found to have elevated BNP of 775 as well as COVID-19 pneumonia.  She was therefore admitted as a case of acute hypoxic respiratory failure secondary to COVID-19 pneumonia as well as acute CHF exacerbation, diastolic dysfunction.  He was treated with antibiotics, and steroids for her COVID-19.  She did well from that standpoint
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diastolic dysfunction, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient recently tested positive for COVID-19 approximately 9 days prior to presentation.  He currently presented to the hospital with worsening shortness of breath that started approximately 1 week prior to presentation.In the emergency room she was found to have elevated BNP of 775 as well as COVID-19 pneumonia.  She was therefore admitted as a case of acute hypoxic respiratory failure secondary to COVID-19 pneumonia as well as acute CHF exacerbation, diastolic dysfunction.  He was treated with antibiotics, and steroids for her COVID-19.  She did well from that standpoint
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Walking distance test
Clinical narrative: Pneumonia due to COVID-19-has been treated with IV steroids. Presented with SOB, cough. Id has been on board.  Has needed 2 L oxygen while here but walk study done did not qualify her for any home O2.  She has been cleared for discharge by ID on short course of steroids
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Dyspnoea, Fatigue, Loss of personal independence in daily activities
Clinical narrative: The patient is a 37-year-old male who was brought to the emergency room by ambulance.  He tested positive for COVID as an outpatient on January 10.  He began to have some symptoms of shortness of breath beginning January 8.  He received a prescription for Medrol Dosepak and was taking vitamin C and zinc.  However, after completing the Medrol Dosepak, he again began having symptoms, which now included fatigue, noted to be quite severe and limiting his activity.  On the admission day, he was brought to the ER by ambulance, and he developed central chest tightness with shortness of breath.  EMS found him extremely distressed with difficulty breathing, and he received 125 mg of Solu-Medrol in the field.  The patient was kept on Solu-Medrol and agreed for remdesivir therapy.  He also received supportive care that included supplements and Singulair.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: The patient is a 37-year-old male who was brought to the emergency room by ambulance.  He tested positive for COVID as an outpatient on January 10.  He began to have some symptoms of shortness of breath beginning January 8.  He received a prescription for Medrol Dosepak and was taking vitamin C and zinc.  However, after completing the Medrol Dosepak, he again began having symptoms, which now included fatigue, noted to be quite severe and limiting his activity.  On the admission day, he was brought to the ER by ambulance, and he developed central chest tightness with shortness of breath.  EMS found him extremely distressed with difficulty breathing, and he received 125 mg of Solu-Medrol in the field.  The patient was kept on Solu-Medrol and agreed for remdesivir therapy.  He also received supportive care that included supplements and Singulair.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Eye discharge, Influenza like illness, Ocular hyperaemia
Clinical narrative: flu like symptoms and possible eye infection blood shot eyes and gooey discharged from eyes
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 32.0
Sex: M
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: Patient asked for Spikevax, however was billed and administered for the fluarix.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dehydration, Diarrhoea, Hypophagia, Mental status changes
Clinical narrative: Presents with diarrhea, poor PO intake, AMS. Positive for Covid on 2/22/22. No remdesivir/dexamethasone. Dehyrdation resolved with IV fluids and supportive care.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presents with diarrhea, poor PO intake, AMS. Positive for Covid on 2/22/22. No remdesivir/dexamethasone. Dehyrdation resolved with IV fluids and supportive care.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea, Hypoxia, Inflammatory marker test, Procalcitonin normal
Clinical narrative: Patient is a 70 y.o. female who was admitted with increasing SOB, fevers.  COVID 19 PNA with acute hypoxia  - stable now on RA. Cont steroid taper at home  - given Remdesivir. Inflammatory markers improved -  procalitonin nl,  abx discontinued
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Patient is a 70 y.o. female who was admitted with increasing SOB, fevers.  COVID 19 PNA with acute hypoxia  - stable now on RA. Cont steroid taper at home  - given Remdesivir. Inflammatory markers improved -  procalitonin nl,  abx discontinued
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Patient having progressive generalized weakness, diarrhea.  Bilateral lower lobe pneumonia:  Pneumonia protocol, Covid 19 positive placed on COVID-19 protocol
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Pulse absent, Respiratory failure, Resuscitation
Clinical narrative: Resident was found pulseless and without respirations, was pronounced dead at  0445 after unsuccessful CPR.
Age: 78.0
Sex: F
Vaccine: PNC20, RSV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: patient reported redness, heat, pain and swelling for 4 days in upper arms with the left arm feeling worse. she reported reaction to family doctor. reaction started on 11/1/2023 and lasted for 4 days. she has now recovered.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vacine formulation administered
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Product preparation error, Pyrexia
Clinical narrative: Patient received Moderna Spikevax 2023-2024 Formula on 10/30/2023. Our time was given some training before administering the vaccine, but we did not know that the vaccine needed a thaw time and Medical Assistant was applying heat to the Frozen vaccine with her hands for up to 15-20 min max until it turned into liquid. Patient has been called and stated she had fever for less than 2 days and noticed that a little bump was on the site where she received the vaccine (left deltoid), pt did not went to urgent care/ hospital/ emergency room. Patient was informed about the administration error of the vaccine, I did explain to her that we are submitting a VAERS report. After a week receiving the vaccine, patient states she has been feeling very well and no other concerns.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site swelling
Clinical narrative: PATIENT REPORTS INFLAMMATION, SWELLING AT INJECTION SITE
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pt was given the 0.5ml dose of the 6m-11yr COVID vaccine instead of the 0.25ml dose.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Lung infiltration, Procalcitonin increased
Clinical narrative: Presented from Rehab after testing positive for COVID-19. Initially patient was asymptomatic, but overnight on first night increased to 2L O2 oxygen requirement. Additionally bilateral infiltrates noted on CXR and procalcitonin elevated, suspected worsening COVID-19 pneumonia. Patient was placed on 5 day course of ceftriaxone, initially on doxy but stopped after negative MRSA screen and viral panel for atypicals. Additionally was placed on Decadron 6mg x10 days and Remdesivir x5 days for COVID management.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Staphylococcus test negative, Viral test
Clinical narrative: Presented from Rehab after testing positive for COVID-19. Initially patient was asymptomatic, but overnight on first night increased to 2L O2 oxygen requirement. Additionally bilateral infiltrates noted on CXR and procalcitonin elevated, suspected worsening COVID-19 pneumonia. Patient was placed on 5 day course of ceftriaxone, initially on doxy but stopped after negative MRSA screen and viral panel for atypicals. Additionally was placed on Decadron 6mg x10 days and Remdesivir x5 days for COVID management.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19 pneumonia, Cough, Dyspnoea
Clinical narrative: Admitted complaining of coughh, SOB, and generalized weakness. COVID-19 pneumonia complicated by acute hypoxemic respiratory failure, antibiotic coverage with ceftriaxone and doxycycline, IV steroids, Remdesivir, Refused Bari. Disposition: Unfortunately patient decided to leave against medical advice despite my best efforts to convince him to stay as he still required 6 L of oxygen on nasal cannula
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Cough, Dyspnoea, Hypoxia
Clinical narrative: Presented complaining of worsening cough and shortness of breath.  Her workup revealed her to have COVID-19 pneumonia.  She was found to be hypoxic with O2 sats 90% on room air and started on supplemental oxygen. COVID-19 Pneumonia with acute hypoxemic respiratory failure. Elevated procalcitonin, treated with IV antibiotics in the hospital and discharged with Cefpodoxime. Completed remdesivir, last dose 2/16/21 Discharge home with dexamethasone to complete the course.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Procalcitonin increased
Clinical narrative: Presented complaining of worsening cough and shortness of breath.  Her workup revealed her to have COVID-19 pneumonia.  She was found to be hypoxic with O2 sats 90% on room air and started on supplemental oxygen. COVID-19 Pneumonia with acute hypoxemic respiratory failure. Elevated procalcitonin, treated with IV antibiotics in the hospital and discharged with Cefpodoxime. Completed remdesivir, last dose 2/16/21 Discharge home with dexamethasone to complete the course.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Endotracheal intubation, Hypotension, Insomnia
Clinical narrative: Tested positive for Covid 2 days prior to admission. Brought in by EMS due to unresponsive behavior as well as seizure like activity. On arrival patient was unresponsive but not intubated. She was intubated by the ER and become hypotensive. She was started on vasopressors and critical care was consulted for admission. She had progressive and worsening shock unresponsive to fluid or vasopressors. Per family she had been having fever since Tuesday and had been co,mplaining that her joints hurt. She didn't sleep last night and so her husband was letting her sleep in until around 11am this morning when she became rigid with some shaking. He called EMS who loaded her int he ambulance to bring her to the ER when she had a
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle rigidity, Pyrexia, SARS-CoV-2 test positive, Seizure like phenomena, Shock
Clinical narrative: Tested positive for Covid 2 days prior to admission. Brought in by EMS due to unresponsive behavior as well as seizure like activity. On arrival patient was unresponsive but not intubated. She was intubated by the ER and become hypotensive. She was started on vasopressors and critical care was consulted for admission. She had progressive and worsening shock unresponsive to fluid or vasopressors. Per family she had been having fever since Tuesday and had been co,mplaining that her joints hurt. She didn't sleep last night and so her husband was letting her sleep in until around 11am this morning when she became rigid with some shaking. He called EMS who loaded her int he ambulance to bring her to the ER when she had a
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Unresponsive to stimuli
Clinical narrative: Tested positive for Covid 2 days prior to admission. Brought in by EMS due to unresponsive behavior as well as seizure like activity. On arrival patient was unresponsive but not intubated. She was intubated by the ER and become hypotensive. She was started on vasopressors and critical care was consulted for admission. She had progressive and worsening shock unresponsive to fluid or vasopressors. Per family she had been having fever since Tuesday and had been co,mplaining that her joints hurt. She didn't sleep last night and so her husband was letting her sleep in until around 11am this morning when she became rigid with some shaking. He called EMS who loaded her int he ambulance to bring her to the ER when she had a
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pt was given the 0.5ml dose of the 6m-11yr COVID vaccine instead of the 0.5ml of the 12+formulation.
Age: 1.42
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Patient was administered Quadracel vaccine in error. Verbal order was given by the provider. Patient should have received DTap only per vaccine schedule.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Immediate post-injection reaction, Incorrect route of product administration, Injection site inflammation, Injection site nodule, Injection site pain
Clinical narrative: Pt was seen at our clinic on 10/06/2023 for Tdap vaccination. Tdap was ordered by provider. Medication assistant mistakenly administered Tdap as a TB test intradermally in left forearm. Immediate swelling of forearm that worsened over the weekend iwith swelling of her lymph nodes under her arm. Pt was seen in emergency room on 10/07/2023 related to error. Ibuprofen prescribed. PT returned to our clinic on 10/24/2023 to notify us of mistake and follow up of arm pain. This is when we were notified of error. Per MD note  evidence of 1cm nodule in mid-forearm  that is the residual effect of the inflammation and is moderately tender. No evidence of long term damage.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling, Lymphadenopathy, Pain in extremity, Product administered at inappropriate site, Product administration error
Clinical narrative: Pt was seen at our clinic on 10/06/2023 for Tdap vaccination. Tdap was ordered by provider. Medication assistant mistakenly administered Tdap as a TB test intradermally in left forearm. Immediate swelling of forearm that worsened over the weekend iwith swelling of her lymph nodes under her arm. Pt was seen in emergency room on 10/07/2023 related to error. Ibuprofen prescribed. PT returned to our clinic on 10/24/2023 to notify us of mistake and follow up of arm pain. This is when we were notified of error. Per MD note  evidence of 1cm nodule in mid-forearm  that is the residual effect of the inflammation and is moderately tender. No evidence of long term damage.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pt was given the 0.5ml dose of the 6m-11yr COVID vaccine instead of the 0.5ml of the 12+dose formulation.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19  Breakthrough Infection
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic stenosis, COVID-19 pneumonia, Dyspnoea, Echocardiogram abnormal, Hypoxia
Clinical narrative: Presents to the emergency room with progressive shortness of breath for the last few days before admission. The pt was admitted to the hospital on  10/7/2021 because of COVID-19 pneumonia and hypoxia.  Patient was also seen by ID.IV Decadron and IV Remdesivir were continued.  The patient also received Actemra.  Oxygen was weaned.  Patient does not want to go to rehab.  Patient wants to go home.  Yesterday patient also had nonsustained V-tach episode.  Echocardiogram showed moderate to severe aortic stenosis. It was recommended that she discharge to SNF but patient refused and was discharged home with family support.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ventricular tachycardia
Clinical narrative: Presents to the emergency room with progressive shortness of breath for the last few days before admission. The pt was admitted to the hospital on  10/7/2021 because of COVID-19 pneumonia and hypoxia.  Patient was also seen by ID.IV Decadron and IV Remdesivir were continued.  The patient also received Actemra.  Oxygen was weaned.  Patient does not want to go to rehab.  Patient wants to go home.  Yesterday patient also had nonsustained V-tach episode.  Echocardiogram showed moderate to severe aortic stenosis. It was recommended that she discharge to SNF but patient refused and was discharged home with family support.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Dyspnoea exertional, Gait disturbance, Inflammatory marker increased
Clinical narrative: Presented with increasing sob .  Patient was recently d/c from the inpatient service after being admitted for COVID. Was d/c on on steroids, abx and elliquis. Had gone home on O2 but had been increasing it herself. Her breathing continued to get worse so she came to the ER. She is having a hard time ambulating without worsening breathing. She is also having fevers. ID was consulted in the ER and concern for cytokine storm as inflammatory markers going up. Out of window for remdesevir.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Presented with increasing sob .  Patient was recently d/c from the inpatient service after being admitted for COVID. Was d/c on on steroids, abx and elliquis. Had gone home on O2 but had been increasing it herself. Her breathing continued to get worse so she came to the ER. She is having a hard time ambulating without worsening breathing. She is also having fevers. ID was consulted in the ER and concern for cytokine storm as inflammatory markers going up. Out of window for remdesevir.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Vertigo/Dizziness - moderate -severe dizzy for 12 hours, currently mild dizziness 24 hours later Was advised it should clear up but if not to notify doctor
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo/Dizziness - moderate -severe dizzy for 12 hours, currently mild dizziness 24 hours later Was advised it should clear up but if not to notify doctor
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Angiogram pulmonary abnormal, COVID-19, Cerebral infarction, Cystitis
Clinical narrative: Patient was sent to hospital because of change in mental status.  The pt was admitted to the hospital on  12/15/2021 because of acute encephalopathy due to COVID-19 cystitis.  IV ceftriaxone was continued.  IV steroids continued.  Patient also had seizure activity.  Patient was transferred to ICU.  MRI showed acute infarction left MCA distribution.  The patient was transferred to floor.  Patient also completed Remdesivir.  Patient oxygen requirement increased.  CTA chest showed pulmonary embolism.  Patient also developed acute renal failure and nephrology was consulted.  Kidney function worsening.  Patient family agreed with hospice.  Will discharge patient to nursing home with hospice
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Encephalopathy, Intensive care, Magnetic resonance imaging head abnormal, Mental status changes, Pulmonary embolism
Clinical narrative: Patient was sent to hospital because of change in mental status.  The pt was admitted to the hospital on  12/15/2021 because of acute encephalopathy due to COVID-19 cystitis.  IV ceftriaxone was continued.  IV steroids continued.  Patient also had seizure activity.  Patient was transferred to ICU.  MRI showed acute infarction left MCA distribution.  The patient was transferred to floor.  Patient also completed Remdesivir.  Patient oxygen requirement increased.  CTA chest showed pulmonary embolism.  Patient also developed acute renal failure and nephrology was consulted.  Kidney function worsening.  Patient family agreed with hospice.  Will discharge patient to nursing home with hospice
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Renal impairment, Seizure like phenomena
Clinical narrative: Patient was sent to hospital because of change in mental status.  The pt was admitted to the hospital on  12/15/2021 because of acute encephalopathy due to COVID-19 cystitis.  IV ceftriaxone was continued.  IV steroids continued.  Patient also had seizure activity.  Patient was transferred to ICU.  MRI showed acute infarction left MCA distribution.  The patient was transferred to floor.  Patient also completed Remdesivir.  Patient oxygen requirement increased.  CTA chest showed pulmonary embolism.  Patient also developed acute renal failure and nephrology was consulted.  Kidney function worsening.  Patient family agreed with hospice.  Will discharge patient to nursing home with hospice
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Computerised tomogram thorax abnormal, Cough, Dyspnoea
Clinical narrative: The patient presents to the hospital today with cough, shortness of breath, weakness. Diagnosed with COVID-19 on 01/25/2022. Symptoms started 01/20/2022. Was on azithromycin as well as Molnupiravir for least the last 3 days. CT chest shows bilateral infiltrates in lungs. CT angiogram could not be done due to allergy to iodine. V/Q scan - The probability of pulmonary embolism is very low. DVT scan negative. Continues to be on 3 L.Continued on dexamethasone. Does not qualify for remdesivir - symptoms more than 10 days.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, Ultrasound Doppler normal, Ventilation/perfusion scan
Clinical narrative: The patient presents to the hospital today with cough, shortness of breath, weakness. Diagnosed with COVID-19 on 01/25/2022. Symptoms started 01/20/2022. Was on azithromycin as well as Molnupiravir for least the last 3 days. CT chest shows bilateral infiltrates in lungs. CT angiogram could not be done due to allergy to iodine. V/Q scan - The probability of pulmonary embolism is very low. DVT scan negative. Continues to be on 3 L.Continued on dexamethasone. Does not qualify for remdesivir - symptoms more than 10 days.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 4.0
Sex: F
Vaccine: DTAP, FLU4
Symptoms: Erythema, Feeling hot, Oedema
Clinical narrative: Edema, warmth, erythema
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, COVID-19, Hypoxia, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Patient is a 67 y.o. male who presented with low oxygen readings at home, noted to be in the 70s on room air, does not use oxygen at home.  In the ER noted to be hypoxic, placed on supplemental O2, COVID19 positive.  Patient was admitted, Infectious Disease consulted, treated with Decadron, 3 doses of Remdesivir.  Patient had significant improvement symptoms, was weaned off of supplemental O2, passed walk study.  During hospital course, noted to be bradycardic, metoprolol and Imdur doses adjusted with hold parameters.  Patient did not have any symptoms of bradycardia.  He was  Discharged home in stable condition.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Walking distance test normal
Clinical narrative: Patient is a 67 y.o. male who presented with low oxygen readings at home, noted to be in the 70s on room air, does not use oxygen at home.  In the ER noted to be hypoxic, placed on supplemental O2, COVID19 positive.  Patient was admitted, Infectious Disease consulted, treated with Decadron, 3 doses of Remdesivir.  Patient had significant improvement symptoms, was weaned off of supplemental O2, passed walk study.  During hospital course, noted to be bradycardic, metoprolol and Imdur doses adjusted with hold parameters.  Patient did not have any symptoms of bradycardia.  He was  Discharged home in stable condition.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure, Cardiac failure congestive, Cough, Dyspnoea exertional
Clinical narrative: Covid positive 1.20.22. Presents with worsening DOE and mild cough. Decompensated CHF. Treated with lasix and antibiotics.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid positive 1.20.22. Presents with worsening DOE and mild cough. Decompensated CHF. Treated with lasix and antibiotics.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Confusional state, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: sent to the emergency department with confusion and weakness and fever. Treated with dexamethasone. Covid positive on 12.28.23.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulationadministered
Age: 72.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: PATIENT MISTAKENLY RECEIVED 2 SHOTS OF RSV VACCINES INSTEAD OF 1 MODERNA AND 1 RSV
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC20, RV5
Symptoms: Barium double contrast, Differential white blood cell count, Full blood count, Haematochezia, Intussusception
Clinical narrative: Patient had bloody stool, jelly like consistency.  Patient was seen in primary care clinic and then sent to hospital.  Pt was diagnosed with intussusception.  Pt had two air enemas were performed for reduction.  Patient was monitored in ED for four hours post reduction and discharged home.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC20, RV5
Symptoms: Ultrasound abdomen abnormal
Clinical narrative: Patient had bloody stool, jelly like consistency.  Patient was seen in primary care clinic and then sent to hospital.  Pt was diagnosed with intussusception.  Pt had two air enemas were performed for reduction.  Patient was monitored in ED for four hours post reduction and discharged home.
Age: 82.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Chills, Headache, Pain
Clinical narrative: approximately 5.5 hrs after receiving her vaccination, the patient developed chills, headache, bodyaches and weakness, lasting approximately 4 days. She did not seek medical treatment for this
Age: 78.0
Sex: F
Vaccine: PNC20, RSV, VARZOS
Symptoms: Headache, Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Patient reports pounding headaches every day since vaccination ("like someone is hitting her with a hammer"), a large, itchy red bump at the site of vaccination that has not improved, and a very sore arm.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Device malfunction, Device use issue
Clinical narrative: Improper holding and equipment malfunction.  Dr and parent talked and parent advised to come back for another dose in 30 days.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vaccine formulation administered
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product use issue
Clinical narrative: Parent had not consented to daughter receiving COVID19 vaccine. Vaccine was ordered in error by provider, then given by clinical support staff member. No adverse reactions noted. Parent and patient made aware of error.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: wrong vaccine formulation administered
Age: 64.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: Localized rash, redness, and sore arm
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Cough, Increased viscosity of bronchial secretion, Productive cough, Secretion discharge, Sinusitis
Clinical narrative: Dry hacking Cough began within 6 hrs of vaccine, becoming productive within 5 days, mucous continuing from clear to yellow/ green to thick tan on Nov 3, ARNP appt 11/8 = sinus infection, started Augmentin bid x 2 daily, Flonase, Albuterol, Benzonatate.
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Sputum discoloured
Clinical narrative: Dry hacking Cough began within 6 hrs of vaccine, becoming productive within 5 days, mucous continuing from clear to yellow/ green to thick tan on Nov 3, ARNP appt 11/8 = sinus infection, started Augmentin bid x 2 daily, Flonase, Albuterol, Benzonatate.
Age: 80.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Vomiting
Clinical narrative: Pt stated that she had severe diarrhea and vomiting that lasted for about 10 hours following the vaccine (11/3-11/4). I asked if she took anything to help with the symptoms and she stated she could not keep anything down so she did not. Pt felt fine after the symptoms went away. I told pt to make sure her dr knows about this reaction as well and that I would report it and place a note on her profile.
Age: 15.0
Sex: M
Vaccine: COVID19, HEP, HPV9, IPV, MMR, TDAP, VARCEL
Symptoms: Pruritus
Clinical narrative: After administering the above vaccinations, client began itching his back and neck and stated he was itchy. Nurse administered .5 ml of Benadryl and monitored client for 15-20 minutes following. Client verbalized relief of itching and denied any other symptoms.